by Emily Henderson, B.Sc.Sep 16 2020 A collaborative study led by Monash University’s Biomedicine Discovery Institute and the Olivia Newton-John Cancer Research Institute (ONJCRI) has uncovered new markers (HLA-associated peptides) that are uniquely present on melanoma tumors and could pave the way for therapeutic vaccines to be developed in the fight against melanoma. Despite all improvements...